Search

Your search keyword '"Bijlmer, H.A."' showing total 2 results
Start Over Author "Bijlmer, H.A." Topic serology
2 results on '"Bijlmer, H.A."'

1. Chronic Q fever: Review of the literature and a proposal of new diagnostic criteria

Author

Wegdam-Blans, M.C., Kampschreur, L.M., Delsing, C.E., Bleeker-Rovers, C.P., Sprong, T., Kasteren, M.E.E. van, Notermans, D.W., Renders, N.H., Bijlmer, H.A., Lestrade, P.J., Koopmans, M.P., Nabuurs-Franssen, M.H., Oosterheert, J.J., Galama, J.M.D., Epidemiologie, and RS: CAPHRI School for Public Health and Primary Care

Subjects
Diagnostic Imaging, Microbiology (medical), medicine.medical_specialty, MEDLINE, Clinical Chemistry Tests, Diagnostic tools, Serology, Invasive mycoses and compromised host [N4i 2], Chronic Q fever, medicine, Vascular infections, Humans, Endocarditis, Intensive care medicine, biology, business.industry, Pathogenesis and modulation of inflammation Infection and autoimmunity [N4i 1], Guideline, Coxiella burnetii, biology.organism_classification, medicine.disease, Pathogenesis and modulation of inflammation [N4i 1], Chronic infection, Infectious Diseases, Immunology, Q Fever, business
Abstract

Item does not contain fulltext A review was performed to determine clinical aspects and diagnostic tools for chronic Q fever. We present a Dutch guideline based on literature and clinical experience with chronic Q fever patients in The Netherlands so far. In this guideline diagnosis is categorized as proven, possible or probable chronic infection based on serology, PCR, clinical symptoms, risk factors and diagnostic imaging. 01 maart 2012

Published
2012

2. A Dutch nationwide evaluation of serological assays for detection of Borrelia antibodies in clinically well-defined patients.

Author

Ang, C.W., Brandenburg, A.H., van Burgel, N.D., Bijlmer, H.A., Herremans, T., Stelma, F., Lunel, F. Verduyn, and van Dam, A.P.

Subjects
*SEROLOGY, *BORRELIA diseases, *BACTERIAL diseases, *IMMUNOGLOBULINS, *BORRELIA burgdorferi, *COMPARATIVE studies, *PATIENTS
Abstract

Numerous tests for the detection of antibodies against Borrelia burgdorferi are commercially available. Manufacturer-derived data invariably report a high sensitivity and specificity, but comparative studies demonstrate large differences in clinical practice, especially with regard to specificity. We retrospectively collected data from validation studies for B. burgdorferi antibody assays from 8 laboratories in the Netherlands. The total number of samples was 809. Samples were selected based on clinical and laboratory parameters. We included samples from patients with erythema migrans, acrodermatitis chronicum atrophicans, and neuroborreliosis; cross-reactivity controls; and healthy controls. Data are presented from 10 enzyme-linked immunosorbent assays and 5 immunoblots. For manifestations of B. burgdorferi infection with short disease duration, the positivity rate of the assays varied significantly. In patients with long disease duration, the positivity rate differed only marginally. In cross-reactivity controls, there was significant variation in the reactivity rate. The majority of false-positive reactions are of the IgM isotype. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results